Login / Signup
Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic disease.
Alexis Arasu
Niyati Sharma
Anousha Yazdabadi
Michael J Sladden
Published in:
The Australasian journal of dermatology (2021)
Keyphrases
</>
atopic dermatitis
rheumatoid arthritis
mesenchymal stem cells
smoking cessation
replacement therapy